Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-24-021243

Options or other derivatives

  • EVP, Head of Research & Dev acquired 389,126 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Thompson Elizabeth H.Z. EVP, Head of Research & Dev 2024-08-12 Grant or award · Stock Option (Right to Buy) +324,582 324,582 D
Thompson Elizabeth H.Z. EVP, Head of Research & Dev 2024-08-12 Grant or award · Restricted Stock Units +64,544 64,544 D
Loading xslF345X05/form4-08132024_060801.xml…